BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 111829
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.111829
Table 4 Efficacy of precision intervention based on propensity score matching
Outcome measures
Intervention group (n = 76)
Conventional group (n = 76)
Relative risk/mean difference (95%CI)
P value
Primary outcomes
28-day all-cause mortality12 (15.8)19 (25.0)0.63 (0.33-0.98)0.043
180-day mortality15 (19.7)23 (30.3)0.65 (0.37-0.92)0.038
Secondary outcomes
MODS37 (48.7)47 (61.8)0.79 (0.58-0.96)0.027
Abdominal compartment syndrome16 (21.1)27 (35.5)0.59 (0.35-0.87)0.011
ICU admission44 (57.9)51 (67.1)0.86 (0.67-1.03)0.172
ICU LOS (days), mean ± SD7.8 ± 4.510.3 ± 5.8-2.5 (-4.1 to -0.9)0.029
Mechanical ventilation19 (25.0)27 (35.5)0.70 (0.43-1.05)0.078
Mechanical ventilation duration (days), mean ± SD4.6 ± 3.16.9 ± 4.0-2.3 (-3.4 to -1.2)0.003
Infectious complications24 (31.6)32 (42.1)0.75 (0.49-0.98)0.047
Hospital LOS (days), mean ± SD18.4 ± 8.622.7 ± 10.1-4.3 (-7.1 to -1.5)0.036
Total cost (× 10000 RMB), mean ± SD10.3 ± 5.613.8 ± 7.3-3.5 (-5.6 to -1.4)0.021
Subgroup analysis
Hypertriglyceridemic AP subgroup (n = 28 pairs)
MODS11 (39.3)17 (60.7)0.65 (0.38-0.94)0.018
28-day mortality4 (14.3)8 (28.6)0.50 (0.22-0.99)0.041
Biliary AP subgroup (n = 40 pairs)
MODS21 (52.5)28 (70.0)0.75 (0.52-0.98)0.032
28-day mortality7 (17.5)10 (25.0)0.70 (0.37-1.33)0.263
Alcoholic AP subgroup (n = 16 pairs)
MODS9 (56.3)11 (68.8)0.82 (0.47-1.43)0.465
28-day mortality3 (18.8)4 (25.0)0.75 (0.21-2.65)0.659
Adjusted analysis
28-day mortality, adjusted OR1--0.59 (0.29-0.97)0.038
MODS, adjusted OR1--0.71 (0.41-0.93)0.023


Write to the Help Desk